Cargando…
LncRNA MIAT enhances systemic lupus erythematosus by upregulating CFHR5 expression via miR-222 degradation
Systemic lupus erythematosus (SLE), a complex polygenic autoimmune disease, is associated with increased complement activation. Complement factor H related protein 5 (CFHR5) may contribute to dysfunctional complement activation, thus predisposing to SLE. The expression levels of anti-dsDNA, C3 and C...
Autores principales: | Zhang, Yali, Xie, Liyi, Lu, Wanhong, Lv, Jing, Li, Yan, Shao, Yaozhong, Sun, Jiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056357/ https://www.ncbi.nlm.nih.gov/pubmed/33897280 http://dx.doi.org/10.5114/ceji.2021.105242 |
Ejemplares similares
-
LncRNA-MIAT Increased in Patients with Coronary Atherosclerotic Heart Disease
por: Tan, Jin, et al.
Publicado: (2019) -
lncRNA MIAT promotes cell invasion and migration in esophageal cancer
por: Zhang, Weiguo, et al.
Publicado: (2020) -
Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure
por: Yang, Liu, et al.
Publicado: (2021) -
Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy
por: Wang, Ziyang, et al.
Publicado: (2022) -
LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
por: Ye, Zi-ming, et al.
Publicado: (2019)